文献速递性腺与生殖内分泌肥胖与代谢综合征

绝经后女性在接受与未接受绝经激素治疗时的脂肪组织性激素

Adipose Tissue Sex Steroids in Postmenopausal Women With and Without Menopausal Hormone Therapy.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究比较了63例绝经后女性(口服绝经激素治疗50例、未治疗13例)皮下与内脏脂肪组织中雌酮、雌二醇、孕酮、睾酮、雄烯二酮、脱氢表雄酮及血清雌酮硫酸盐浓度,并检测类固醇硫酸酯酶活性与性激素代谢酶及受体基因mRNA表达;接受治疗者脂肪组织雌酮和雌二醇高4至7倍、内脏脂肪睾酮低30%,雌激素与雄激素比值高4至12倍,且内脏脂肪该比值随雌二醇剂量升高。

要点

  • 接受绝经激素治疗者皮下与内脏脂肪雌酮、雌二醇浓度比未接受者高4至7倍。
  • 接受治疗者内脏脂肪睾酮比未接受者低30%,脂肪组织雌激素与雄激素比值高4至12倍。
  • 接受治疗者内脏脂肪雌激素与雄激素比值随激素治疗雌二醇剂量升高。

核心结论

  • 接受绝经激素治疗者局部雌激素与雄激素比值较高、脂肪组织与血清雌激素浓度比值较高,提示激素治疗可能显著影响脂肪组织内的性激素 intracrine 代谢;这些局部变化可能参与激素治疗对绝经相关腹部肥胖的预防作用。

研究设计与样本

  • 研究纳入63例绝经后女性,其中接受口服绝经激素治疗50例、未接受13例。
  • 采用液相色谱-串联质谱法测定血清及皮下、内脏脂肪组织中雌酮、雌二醇、孕酮、睾酮、雄烯二酮、脱氢表雄酮及血清雌酮硫酸盐。
  • 以放射性标记底物测定类固醇硫酸酯酶活性,并以实时逆转录定量聚合酶链反应检测性激素代谢酶及受体基因mRNA表达。

主要发现

  • 接受激素治疗者皮下和内脏脂肪组织中雌酮和雌二醇浓度比未接受者高4至7倍。
  • 接受激素治疗者内脏脂肪组织中睾酮比未接受者低30%。
  • 接受激素治疗者脂肪组织中雌激素与雄激素比值比未接受者高4至12倍。
  • 在内脏脂肪组织中,雌激素与雄激素比值随激素治疗雌二醇剂量升高而增加。
  • 接受激素治疗者脂肪组织与血清的雌酮和雌二醇比值仍保持较高水平。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The decrease in serum estrogens after menopause is associated with a shift from a gynoid to an android adipose tissue (AT) distribution. Menopausal hormone therapy (HT) mitigates this change and accompanying metabolic dysfunction, but its effects on AT sex steroid metabolism have not been characterized. OBJECTIVE: We studied effects of HT on subcutaneous and visceral AT estrogen and androgen concentrations and metabolism in postmenopausal women. DESIGN, SETTING, PATIENTS, AND INTERVENTIONS: Serum and subcutaneous and visceral AT from 63 postmenopausal women with (n = 50) and without (n = 13) per oral HT were analyzed for estrone, estradiol, progesterone, testosterone, androstenedione, dehydroepiandrosterone, and serum estrone sulfate using liquid chromatography-tandem mass spectrometry. Steroid sulfatase activity was measured using radiolabeled precursors. mRNA expression of genes encoding sex steroid-metabolizing enzymes and receptors was performed using real-time reverse transcription quantitative polymerase chain reaction. RESULTS: HT users had 4- to 7-fold higher concentrations of estrone and estradiol in subcutaneous and visceral AT, and 30% lower testosterone in visceral AT compared to nonusers. Estrogen-to-androgen ratios were 4- to 12-fold higher in AT of users compared to nonusers of HT. In visceral AT, estrogen-to-androgen ratios increased with HT estradiol dose. AT to serum ratios of estrone and estradiol remained high in HT users. CONCLUSION: Higher local estrogen to androgen ratios and high AT to serum ratios of estrogen concentrations in HT users suggest that HT may significantly influence intracrine sex steroid metabolism in AT; these local changes could be involved in the preventive effect of HT on menopause-associated abdominal adiposity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hetemäki N, Robciuc A, Vihma V, et al. Adipose Tissue Sex Steroids in Postmenopausal Women With and Without Menopausal Hormone Therapy. J Clin Endocrinol Metab. 2025. PMID: 38986008. doi:10.1210/clinem/dgae458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。